Cite
MLA Citation
Gerd R Burmester et al.. “A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study).” Annals of the rheumatic diseases, vol. 73, no. 1, 2014, pp. 69–74. http://access.bl.uk/ark:/81055/vdc_100135567342.0x000060